Biosimilars Development Strategies

Explore the future of biopharmaceuticals with Biosimilars Development Strategies by Sarfaraz Niazi, published by Taylor & Francis Ltd in 2024. This insightful hardback edition spans 188 pages and offers a comprehensive update on the current status of biosimilars, along with a forward-looking perspective for the next decade.

Niazi delves into the innovative strategies shaping the development of biosimilars, highlighting the integration of AI technologies that will revolutionize the industry. Discover how these advancements will establish structural similarity, potentially reducing the need for extensive testing, including detailed analytical assessments and clinical pharmacology evaluations.

Whether you are a pharmacy professional, researcher, or student, this book serves as an essential resource for understanding the evolving landscape of biosimilars. Stay ahead in the field with expert insights and strategic guidance from a leader in the industry.